RDY
RDY
US2561352038
Dr. Reddy's Laboratories Ltd
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2026 2025 Change %
Total Revenue 335.933.000.000 325.535.000.000
3.2%
Cost of Revenue 158.669.000.000 135.107.000.000
17.4%
Gross Profit 177.264.000.000 190.428.000.000
6.9%
127.141.000.000 118.414.000.000
7.4%
Operating Income 50.123.000.000 72.014.000.000
30.4%
Pretax Income 54.817.000.000 76.784.000.000
28.6%
Net Income Common Stockholders 42.850.000.000 56.544.000.000
24.2%
-- --
--
-- --
--
ende